Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1939
+0.0001 (0.05%)
Apr 23, 2026, 9:34 AM EDT - Market open
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $5.65 million as of April 23, 2026. Its market cap has decreased by -51.23% in one year.
Market Cap
5.65M
Enterprise Value
4.26M
1-Year Change
-51.23%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $5.65M, a decrease of -97.13%. That is a compound annual growth rate of -50.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 5.65M | -40.01% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Purple Biotech | 6.23M |
| Aptevo Therapeutics | 6.06M |
| BioRestorative Therapies | 5.81M |
| Mustang Bio | 5.80M |
| CollPlant Biotechnologies | 5.66M |
| Cardio Diagnostics Holdings | 5.65M |
| Jaguar Health | 5.34M |
| Moolec Science | 5.31M |